|
GB9622386D0
(en)
*
|
1996-10-28 |
1997-01-08 |
Sandoz Ltd |
Organic compounds
|
|
WO1998035967A2
(en)
|
1997-02-18 |
1998-08-20 |
Neurocrine Biosciences, Inc. |
Biazacyclic crf antagonists
|
|
JP2002507996A
(ja)
|
1997-07-03 |
2002-03-12 |
デュポン ファーマシューティカルズ カンパニー |
神経学的障害を治療するためのイミダゾピリミジン類およびイミダゾピリジン類
|
|
NL1010018C2
(nl)
*
|
1997-09-09 |
1999-03-10 |
Duphar Int Res |
Chinoline en chinazoline derivaten met corticotropine releasing factor (CRF) antagonistische werking.
|
|
US6124463A
(en)
*
|
1998-07-02 |
2000-09-26 |
Dupont Pharmaceuticals |
Benzimidazoles as corticotropin release factor antagonists
|
|
US6365589B1
(en)
*
|
1998-07-02 |
2002-04-02 |
Bristol-Myers Squibb Pharma Company |
Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
|
|
US6271380B1
(en)
*
|
1998-12-30 |
2001-08-07 |
Dupont Pharmaceuticals Company |
1H-imidazo[4,5-d]pyridazin-7-ones, 3H-imidazo-[4,5-c]pyridin-4-ones and corresponding thiones as corticotropin releasing factor (CRF) receptor ligands
|
|
US6432989B1
(en)
|
1999-08-27 |
2002-08-13 |
Pfizer Inc |
Use of CRF antagonists to treat circadian rhythm disorders
|
|
OA12050A
(en)
|
1999-09-30 |
2006-05-02 |
Neurogen Corp |
Certain alkylene diamine-substituted heterocycles.
|
|
CA2392992A1
(en)
|
1999-12-17 |
2001-06-21 |
Dupont Pharmaceuticals Company |
Imidazopyrimidinyl and imidazopyridinyl derivatives
|
|
WO2001058489A1
(en)
*
|
2000-02-14 |
2001-08-16 |
Japan Tobacco Inc. |
Preventives/remedies for postoperative stress
|
|
CA2434558A1
(en)
|
2001-01-26 |
2002-08-01 |
Dmitry Zuev |
Imidazolyl derivatives as corticotropin releasing factor inhibitors
|
|
TWI312347B
(en)
*
|
2001-02-08 |
2009-07-21 |
Eisai R&D Man Co Ltd |
Bicyclic nitrogen-containing condensed ring compounds
|
|
WO2002076984A1
(en)
*
|
2001-03-23 |
2002-10-03 |
Smithkline Beecham Corporation |
Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
|
|
WO2002088121A1
(en)
|
2001-04-27 |
2002-11-07 |
Eisai Co., Ltd. |
Pyrazolo[1,5-a]pyridines and medicines containing the same
|
|
GB0117396D0
(en)
|
2001-07-17 |
2001-09-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
US7176216B2
(en)
|
2002-10-22 |
2007-02-13 |
Eisai Co., Ltd. |
7-phenylpyrazolopyridine compounds
|
|
PL213633B1
(pl)
*
|
2002-10-22 |
2013-04-30 |
Eisai R&D Management Co Ltd |
Pochodne 7-fenylopirazolopirydyny, srodek terapeutyczny lub profilaktyczny i zastosowanie
|
|
DE602004009295T2
(de)
|
2003-01-14 |
2008-07-03 |
Arena Pharmaceuticals, Inc., San Diego |
1,2,3-trisubstituierte aryl- und heteroarylderivate als modulatoren des metabolismus zur vorbeugung und behandlung von metabolismus-bedingten krankheiten wie diabetes oder hyperglykämie
|
|
US7034023B2
(en)
*
|
2003-04-04 |
2006-04-25 |
Pfizer Inc |
Pyrrolo[1,2-B]pyridazine compounds and their uses
|
|
GB0308208D0
(en)
|
2003-04-09 |
2003-05-14 |
Glaxo Group Ltd |
Chemical compounds
|
|
US20070021429A1
(en)
*
|
2003-04-09 |
2007-01-25 |
Yves St-Denis |
Condensed n-heterocyclic compounds and their use as crf receptor antagonists
|
|
EP2292620A3
(en)
|
2003-07-14 |
2011-06-22 |
Arena Pharmaceuticals, Inc. |
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prohylaxis and treatment of disorders related thereto
|
|
US20060024661A1
(en)
*
|
2003-07-30 |
2006-02-02 |
The Regents Of The University Of California |
Modulation of CRF potentiation of NMDA receptor currents via CRF receptor 2
|
|
CN1910190A
(zh)
|
2004-01-06 |
2007-02-07 |
大正制药株式会社 |
环氨基取代的噻吩并嘧啶和噻吩并吡啶衍生物
|
|
JP4742273B2
(ja)
*
|
2004-01-06 |
2011-08-10 |
大正製薬株式会社 |
ピロロピリミジン及びピロロトリアジン誘導体
|
|
ATE402180T1
(de)
*
|
2004-03-26 |
2008-08-15 |
Lilly Co Eli |
Verbindungen zur behandlung von dyslipidemie
|
|
GB0428475D0
(en)
*
|
2004-12-30 |
2005-02-02 |
4 Aza Bioscience Nv |
Pyrido(3,2-D)pyrimidine derivatives and pharmaceutical compositions useful as medicines for the treatment of autoimmune disorders
|
|
DE102005007160A1
(de)
*
|
2005-02-16 |
2006-08-24 |
Basf Ag |
Pyrazolcarbonsäureanilide, Verfahren zu ihrer Herstellung und sie enthaltende Mittel zur Bekämpfung von Schadpilzen
|
|
EP1899332A1
(en)
*
|
2005-06-24 |
2008-03-19 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for treating hepatitis c.
|
|
US8338435B2
(en)
*
|
2006-07-20 |
2012-12-25 |
Gilead Sciences, Inc. |
Substituted pyrido(3,2-D) pyrimidines and pharmaceutical compositions for treating viral infections
|
|
TW200840584A
(en)
*
|
2006-12-26 |
2008-10-16 |
Gilead Sciences Inc |
Pyrido(3,2-d)pyrimidines useful for treating viral infections
|
|
WO2008077650A1
(en)
*
|
2006-12-26 |
2008-07-03 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyrimidines useful for treating viral infections
|
|
WO2008077649A1
(en)
*
|
2006-12-26 |
2008-07-03 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyrimidines useful for treating viral infectons
|
|
US8431603B2
(en)
|
2008-04-15 |
2013-04-30 |
Eisai R&D Management Co., Ltd. |
3-phenylpyrazolo[5,1-b]thiazole compounds
|
|
US20110152313A1
(en)
*
|
2008-06-20 |
2011-06-23 |
Macquarie University |
Synthesis of ageladine a and analogs thereof
|
|
US8536187B2
(en)
*
|
2008-07-03 |
2013-09-17 |
Gilead Sciences, Inc. |
2,4,6-trisubstituted pyrido(3,2-d)pyrimidines useful for treating viral infections
|
|
BRPI0916576A2
(pt)
*
|
2008-08-04 |
2017-06-27 |
Chdi Inc |
pelo menos uma entidade química, composição farmacêutica, e, método para tratar uma condição ou distúrbio.
|
|
AR078521A1
(es)
|
2009-10-08 |
2011-11-16 |
Eisai R&D Man Co Ltd |
Compuesto pirazolotiazol
|
|
NZ599597A
(en)
|
2009-10-30 |
2013-05-31 |
Janssen Pharmaceutica Nv |
IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
|
|
AR080754A1
(es)
|
2010-03-09 |
2012-05-09 |
Janssen Pharmaceutica Nv |
Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
|
|
PH12013500547A1
(en)
|
2010-09-22 |
2013-06-10 |
Arena Pharm Inc |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
|
CN102796133B
(zh)
*
|
2011-05-27 |
2015-05-20 |
北京大学 |
一种稀土铕配合物及其作为发光材料的应用
|
|
WO2013000924A1
(en)
|
2011-06-27 |
2013-01-03 |
Janssen Pharmaceutica Nv |
1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES
|
|
EP3243515B1
(en)
|
2011-08-30 |
2019-10-16 |
CHDI Foundation, Inc. |
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
|
|
AU2012300246A1
(en)
*
|
2011-08-30 |
2014-03-06 |
Chdi Foundation, Inc. |
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
|
|
WO2014001314A1
(en)
|
2012-06-26 |
2014-01-03 |
Janssen Pharmaceutica Nv |
Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl- [1,2,4] triazolo [4,3-a] quinoxaline compounds and pde 10 inhibitors for use in the treatment of neurological or metabolic disorders
|
|
AU2013289284B2
(en)
|
2012-07-09 |
2017-03-30 |
Janssen Pharmaceutica Nv |
Inhibitors of phosphodiesterase 10 enzyme
|
|
BR112016000968B1
(pt)
*
|
2013-07-23 |
2021-05-18 |
Bayer Cropscience Aktiengesellschaft |
processo para a preparação de bifenilanilidas halogenadas
|
|
AP2017009724A0
(en)
|
2014-07-17 |
2017-01-31 |
Chdi Foundation Inc |
Methods and compositions for treating hiv-related disorders
|
|
ES2995737T3
(en)
|
2015-01-06 |
2025-02-11 |
Arena Pharm Inc |
Compound for use in treating conditions related to the s1p1 receptor
|
|
MA42807A
(fr)
|
2015-06-22 |
2018-07-25 |
Arena Pharm Inc |
Sel l-arginine cristallin d'acide (r)-2-(7-(4-cyclopentyl-3-(trifluorométhyl)benzyloxy)-1,2,3,4-tétrahydrocyclo-penta[b]indol-3-yl)acétique (composé 1) pour une utilisation dans des troubles associés au récepteur de s1p1
|
|
CA3068350A1
(en)
|
2017-06-30 |
2019-01-03 |
Bayer Animal Health Gmbh |
New azaquinoline derivatives
|
|
EP3801459B1
(en)
|
2018-06-06 |
2024-08-07 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the s1p1 receptor
|
|
MX2021005314A
(es)
*
|
2018-11-09 |
2021-08-24 |
Vivace Therapeutics Inc |
Compuestos biciclicos.
|
|
US12497365B2
(en)
|
2019-01-14 |
2025-12-16 |
Qingdao Kingagroot Chemical Compound Co., Ltd. |
4-pyridinyl formamide compound or derivative thereof, preparation method therefor, herbicidal composition and use thereof
|
|
AU2020257207A1
(en)
|
2019-04-16 |
2021-11-25 |
Vivace Therapeutics, Inc. |
Bicyclic compounds
|
|
WO2025032038A1
(en)
|
2023-08-09 |
2025-02-13 |
Bayer Aktiengesellschaft |
Pyridazin-4-yloxadiazines as novel fungicides
|